To determine whether serum concentrations of OSM and IL-6 also correlate with disease progression and with each other, as seen with breast tumor expression in Figure 1, we assessed serum samples collected from a total of 186 breast cancer patients and healthy individuals by ELISA. Here, IL6 is linked to breast neoplasm.